This important international RCT will aim to improve the long-term health related quality of life for patients with gastro-oesophageal reflux disease through comparison of two established surgical treatments; fundoplication and the LINX procedure. We are hugely excited to undertake this RCT and define the gold standard surgical treatment for gastro-oesophageal reflux disease. - Professor Sheraz R. Markar, Director, Surgical Intervention Trials Unit, University of Oxford

This study is the first large project of its kind to see whether the LINX procedure will give patients less side effects compared to fundoplication. We hope that patients who have the LINX procedure will benefit from feeling less bloating and enables them to burp freely which can be distressing for those effected, but we need the GOLF study to test if this is the case or not. The study will ensure that we have the evidence to show which procedure - LINX or fundoplication - is best in helping to control acid reflux in patients. For patients who do not want to have surgery, or it has not successfully controlled their symptoms, this is an exciting step forward. I am delighted to be part of this study. It is a major step forward in ensuring patients get the best surgical treatment for their acid reflux. - Mimi McCord, Chairman, Trustee & Director, Heartburn Cancer UK